Blockchain Registration Transaction Record

TransCode Therapeutics Advances RNA-Based Cancer Therapeutic in Phase 1a Trial

TransCode Therapeutics announces progress in Phase 1a trial for RNA-based cancer therapeutic TTX-MC138, with expanded enrollment and positive safety profile. Promising results show target engagement and potential for treating metastatic tumors.

TransCode Therapeutics Advances RNA-Based Cancer Therapeutic in Phase 1a Trial

This news highlights the progress of TransCode Therapeutics in developing innovative RNA therapeutics for treating metastatic cancer, demonstrating promising results in its Phase 1a trial. The approval of expanded enrollment and positive safety profile signify a step forward in the fight against cancer, offering hope for patients with metastatic tumors.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xb392aa531e34e0433639375b49fff8e5eebb8d26c8f3db77e96ae795f5d6bf91
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintcornCOkY-4115419145895524b63c7f139f7e77af